The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Syngenta AG

NYSE: SYT
Last

(U.S.) $91.08

Today's change+0.51 +0.56%
Updated April 24 4:04 PM EDT. Delayed by at least 15 minutes.
 

Syngenta AG

NYSE: SYT
Last

(U.S.) $91.08

Today's change+0.51 +0.56%
Updated April 24 4:04 PM EDT. Delayed by at least 15 minutes.

Syngenta AG up (U.S.)$0.51

Syngenta AG closed up Monday by (U.S.)$0.51 or 0.56% to (U.S.)$91.08. Shares have lost 1.41% over the last five days, but sit 1.46% below their 52-week high. This security has underperformed the S&P 500 by 3.30% during the last year.

Key company metrics

  • Open(U.S.) $91.13
  • Previous close(U.S.) $90.57
  • High(U.S.) $91.26
  • Low(U.S.) $90.59
  • Bid / Ask(U.S.) $90.86 / (U.S.) $91.45
  • YTD % change+15.22%
  • Volume1,183,043
  • Average volume (10-day)2,223,407
  • Average volume (1-month)1,232,851
  • Average volume (3-month)824,271
  • 52-week range(U.S.) $74.52 to (U.S.) $92.43
  • Beta1.01
  • Trailing P/E35.54×
  • P/E 1 year forward24.54×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.29
  • Dividend yield2.52%
  • Trailing EPS(U.S.) $2.56
Updated April 24 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.23%

Based on its net profit margin of 9.23%, Syngenta AG is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.63%Sector:Industry:

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q2/2016Q4/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Jun 30, 201606/30/2016Dec 31, 201512/31/2015Jun 30, 201506/30/2015
Revenue5,6967,0945,7777,634
Total other revenue--------
Total revenue5,6967,0945,7777,634
Gross profit2,7643,5252,5983,771
Total cost of revenue2,9323,5693,1793,863
Total operating expense5,4005,7435,5026,068
Selling / general / administrative1,4631,3501,4201,379
Research & development639652674688
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)320145222166
Other operating expenses, total--------
Operating income2961,3512751,566
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1351,2261221,470
Income after tax1151,0661201,224
Income tax, total201602246
Net income1141,0641181,221
Total adjustments to net income--------
Net income before extra. items1141,0641181,221
Minority interest-1-2-2-3
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1141,0641181,221
Inc. avail. to common incl. extra. items1141,0641181,221
Diluted net income1141,0641181,221
Dilution adjustment--------
Diluted weighted average shares92929292
Diluted EPS excluding extraordinary itemsvalue per share1.2411.581.2813.25
Dividends per sharevalue per share--0.0010.980.00
Diluted normalized EPSvalue per share5.1813.624.2915.39